Baylor Jack and Jane Hamilton Heart and Vascular Hospital (BHVH) transcatheter aortic valve replacement (TAVR) team recently placed the first commercially approved Evolut™ PRO system in Texas. This is also the first Evolut PRO valve placed in a failed bioprosthetic aortic valve in the U.S.

"The Evolut PRO has a unique "skirt" around the valve that helps minimize leakage; one of the greatest potential risks for TAVR patient outcomes," said Robert Stoler, MD, co–medical director of cardiology and medical director, Baylor Heart and Vascular Hospital catheterization lab. "In this procedure, we replaced an old, surgically implanted bioprosthetic aortic valve using a minimally invasive approach, without open–heart surgery."

"The addition of the Evolut PRO valve to the program at BHVH continues to bring an advanced generation of research and commercially available valves to aortic stenosis patients in the North Texas region," Dr. Stoler added. "We are pleased to be the first in Texas and one of the first in the U.S. to use this new technology."